Efficacy and Toxicity of Bepotastine 1,5% PF vs Olopatadine 0,2% With BAK on Allergic Conjunctivitis Treatment

Clinical trial NCT04776096 · COMPLETED

Trial details

NCT number: NCT04776096
Sponsor: Laboratorios Poen
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Allergic Conjunctivitis

Start date: 2021-03-10
Primary completion: 2022-08-18
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.